While the COVID-19 global pandemic continues to evolve, we at BD Biosciences believe that scientific research is critical to better understanding and ultimately battling this disease. Now more than ever, BD Biosciences is committed to being your partner and providing you with the tools and support required to enable your COVID-19 research.
We provide a comprehensive portfolio of research tools to facilitate discovery in the following areas of COVID-19 research:
Navigate this site to learn more about BD Biosciences' solutions and their applications in COVID-19 research. All products mentioned on these pages are for research use only, with the exception of the BD FACSLyric™ Flow Cytometer, which is an IVD instrument that can also be used in research. Its use in COVID-19 is for research purposes only.
For information on BD’s comprehensive COVID-19 response efforts—including product availability, status of BD operations and business continuity planning—visit bd.com/COVID-19
COVID-19, or Coronavirus Disease 2019, is caused by the SARS-CoV-2 virus. SARS-CoV-2 is a novel virus belonging to the Coronavirus family, which includes less pathogenic strains responsible for the common cold, as well as the viruses responsible for SARS and MERS. It is genetically related to the coronavirus responsible for the SARS outbreak in 2003.
Key structural proteins of the virus include the spike (S) glycoprotein, the envelope (E) protein and the matrix (M) transmembrane glycoprotein. S protein is responsible for receptor binding, membrane fusion and hemagglutinin activity, and is a target for eliciting host neutralizing antibody. E protein is important for virus infectivity and interacts with the M protein to form the viral envelope.
As the COVID-19 pandemic continues to affect the world’s population, a more detailed understanding of host immune responses may help provide a clearer picture of how the pathogen causes disease in some individuals while most infected people may only show mild or no symptoms at all. Also, an understanding of immune correlates (potential biomarkers) of protection as well as long-term immune memory from convalescent individuals may aid in the design of prophylactic and therapeutic measures for future outbreaks of similar or other coronaviruses.
As the COVID-19 pandemic continues to spread worldwide, there is a pressing need to understand the biological mechanisms determining disease progression and severity. Early research studies have reported dysfunctional immune responses and alterations in the immune cell composition in COVID-19 patients. The extent of the immune dysregulation appears to correlate with the severity of COVID-19 disease. A deeper understanding of the interactions between SARS-CoV-2 and the host immune system will be required to further understand the pathogenesis of this disease and identify biomarkers that may potentially, be used to predict, monitor and/or prevent COVID-19 progression.
An overview of preliminary studies documenting the immunological changes observed in COVID-19 patients was recently presented by Dr. Maurice O’Gorman and Dr. Andrea Cossarizza.
| Reference | Sample Size | Comparative Analysis | Immunological Changes |
|---|---|---|---|
| Wang et al. The Laboratory Test and Host Immunity of COVID-19 Patients with Different Severity of Illness JCI Insight. 2020 April. PMID: 32324595 |
65 COVID‑19 patients | Extremely Severe vs Severe vs Moderate Cases | Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD45RA+ Naïve Tregs (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%) CD4+ CD45RO+ memory T cells (%) HLA-DR+ activated CD4+ and CD8+ T cells (%) NK cells (%) PD-1+ exhausted CD4+ and CD8+ T cells (%) CD4+ and CD8+ T cells producing IFN-γ (%) Serum amounts of IL-6 and IL-10 (pg/mL) |
| Cheng et al. Clinical and Immunologic Features in Severe and Moderate Coronavirus Disease 2019. J Clin Invest. 2020 May. PMID: 32217835 |
21 COVID‑19 patients | Severe vs Moderate Cases | Total lymphocytes, CD4+ and CD8+ T cells (absolute count) Total B cells (%) CD45RA+ Naïve Tregs (%) CD4+ T cells producing IFN-γ (%) Serum amounts of IL-6, IL-10, TNF, IL-2R (pg/mL) |
| Qin et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020 March. PMID: 32161940 |
452 COVID‑19 patients | Severe vs Moderate Cases | Total lymphocytes, total T cells, CD4+ T cells (absolute count) CD4+ cells (%) CD4+ CD45RA+ naïve T cells (%) CD8+ CD28+ cells (%) Tregs (%) CD4+ CD45RO+ memory T cells (%) Serum amounts of TNF, IL-2R, IL-10, IL-6, IL-8 (pg/mL) |
| Zheng et al. Functional Exhaustion of Antiviral Lymphocytes in COVID-19 Patients. Cell Mol Immunol. 2020 May. PMID: 32203188 |
68 COVID‑19 patients | Severe vs Moderate Cases | Total lymphocytes, CD8+ T cells and NK cells (absolute count) CD8+ T cells and NK cells expressing CD107a (%) CD8+ T cells and NK cells producing GZMB, IFN-γ, IL-2 and TNF (%) NKG2A+ Exhausted CD8+ T cells and NK cells (%) |
| Zheng et al. Elevated Exhaustion Levels and Reduced Functional Diversity of T Cells in Peripheral Blood May Predict Severe Progression in COVID-19 Patients. Cell Mol Immunol. 2020 May. PMID: 32203186 |
6 healthy controls 16 COVID‑19 patients |
Severe vs Moderate vs Healthy Cases | CD4+ T cells producing IFN-α or TNF (%) Polyfunctional CD8+ T cells producing IFN-γ, IL-2 and TNF (%) HLA-DR+ activated CD8+ T cells (%) PD-1+ CTLA-4+ TIGIT+ exhausted CD8+ T cells (%) |
|
Zhou et al. Pathogenic T Cells and Inflammatory Monocytes Incite Inflammatory Storm in Severe COVID-19 Patients. Natl Sci Rev. 2020 March. PMCID: PMC7108005 |
33 COVID‑19 patients | ICU vs No ICU Care | Total T cells, CD4+ and CD8+ T cells, monocytes, NK cells (absolute count) PD-1+TIM-3+ exhausted CD4+ and CD8+ T cells (%) CD4+ T cells producing IL-6 and GM-CSF (%) CD14+CD16+ monocytes producing IL-6 and GM-CSF (%) |
| Huang et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020 February. PMID: 31986264 |
41 COVID‑19 patients | ICU vs No ICU Care | Serum amounts of IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IP-10, MCP-1, G-CSF, GM-CSF, IFN-γ, TNF (pg/mL) |
| Diao et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020 May. PMID: 32425950 |
40 healthy subjects 522 COVID‑19 patients |
ICU vs No ICU Care | Total T cells, CD4+ and CD8+ T cells (absolute count) PD-1+ exhausted CD4+ and CD8+ T cells (%) Serum amounts of IL-6, IL-10, TNF (pg/mL) |
| Evangelos J et al. Complex Immune Dysregulation in COVID-19 Patients With Severe Respiratory Failure. Cell Host Microbe. 2020 April. PMID: 32320677 |
54 COVID‑19 patients | Macrophage Activated Syndrome vs Dysregulated Immune Response vs Intermediate Immune Response | Total CD4+ and CD8+ T cells, NK and B cells (absolute count) HLA-DR expression on monocytes (absolute number of molecules/cell) Neutrophils and macrophages (absolute count) Serum amounts of IL-6 (pg/mL) |
| De Biasi et al. Marked T Cell Activation, Senescence, Exhaustion and Skewing Towards TH17 in Patients with Covid-19 Pneumonia. Research Square doi: 10.21203/rs.3.rs-23957/v1. (Pre-print)* | 20 healthy subjects 21 COVID‑19 patients |
COVID‑19 Patients vs Healthy Subjects | CD8+ naïve and central memory T cells (%) CD4+ and CD8+ TEMRA (%) HLA-DR+ CD38+ activated CD4+ and CD8+ T cells (%) PD-1+ CD57+ exhausted/senescent CD4+ and CD8+ T cells (%) Naïve Tregs (%) CD4+ and CD8+ T cells expressing CD107a (%) CD8+ T cells producing IL-2 or IL-17 (%) CD4+ T cells producing IL-2, IFN-α , TNF, or IL-17 (%) Polyfunctional CD4+ T cells producing IL-2 and IL-17 (%) Serum amounts of CXCL6, IFN-γ, Galectin-1, -3, -9, IL-1α, IL-4, IL-6, IL-7, IL-8, IL-10, IL-15, IL-17, MICA, MIP-2 (CXCL2), CCL2, CCL3, CCL4, TNF (pg/mL) |
*Preprint report. This study has not undergone peer-review and should not be considered conclusive, used to inform clinical practice, or referenced as validated information.
The information on COVID-19 presented in the above table is relevant as of May 2020.
The studies reported here have not been independently validated by BD.
All BD reagents used in these studies are for Research Use Only. Not for use in diagnostic or therapeutic procedures.
BD Biosciences enables COVID-19 research by providing solutions for a comprehensive immunophenotypic, functional and transcriptional analysis of immune cells.
View product information, application data and scientific resources for assays performed on healthy human or murine cells that can also be potentially applicable to COVID-19 research.
| Technology | Application | Description | |
|---|---|---|---|
| Flow cytometry | Immunophenotyping | Dried antibody cocktail for immunophenotypic characterization of human naïve, memory and effector T cells | See Product Description |
| Dried antibody cocktail for immunophenotypic characterization of human regulatory T cells | See Product Description | ||
| Dried antibody cocktail for immunophenotypic characterization of human monocytes | See Product Description | ||
| Assessment of markers associated with T cell exhaustion | Download Data Sheet | ||
| Immunophenotypic characterization of human NK cells | View Webinar | ||
| Download Data Sheet | |||
| Immunophenotypic characterization of human B cells | Download Data Sheet | ||
| Immunophenotypic characterization of murine dendritic cells | Download Data Sheet | ||
| Broad immunophenotypic characterization of major human immune cell lineages | Download Data Sheet | ||
| Broad immunophenotypic characterization of major murine immune cell lineages | Download Data Sheet | ||
| Functional assays | Proliferation, degranulation and intracellular cytokine analysis to assess CD8+ T cell activation | Download Data Sheet | |
| Apoptosis, degranulation and intracellular cytokine analysis to assess NK cell cytotoxicity | Download Data Sheet | ||
| Intracellular cytokine analysis to assess the response of human dendritic cells to Toll-like Receptor agonists | Download Data Sheet | ||
| Quantitation of Th1/Th2/Th17 cytokines produced by activated T cells using BD® Cytometric Bead Array (CBA) | Download Data Sheet | ||
| Cell sorting and single-cell multiomics | Deep cell characterization and cell signature discovery | Identification of immunophenotypic and molecular signatures of chronically stimulated human T cells | Download Scientific Poster |
| View Webinar | |||
| Workflow for discovery and confirmation of cell signatures defining human innate lymphoid cell subsets | Download Data Sheet | ||
| View Webinar | |||
| Deep characterization of human regulatory T cells | Download Data Sheet |
During this challenging time, researchers at the forefront of COVID-19 research need tools to power deeper cellular analysis. BD Biosciences research reagents include innovative dyes and a broad portfolio of human-specific antibodies to deliver more resolution and flexibility for experimental design, saving valuable samples and accelerating the time to critical insights.
Readily available optimized antibody cocktails, gene panels, kits and recommended multicolor flow cytometry panels shown in the tables below can help expedite experiments relevant to COVID-19 research.
| Research Area | Research Application | Product Solution(s) |
|---|---|---|
| Viral Immune Response | Identification of naïve and different memory T cell subsets in human whole blood | BD Horizon™ Dri Memory T Cell * |
| Identification of naïve and different effector regulatory T cell (Treg) subsets in human whole blood | BD Horizon™ Dri Treg Cell* | |
| Identification of classical (M1), intermediate (M2) and non-classical (M3) monocyte subsets in human whole blood | BD Horizon™ Dri MonoSet Panel* | |
| Targeted human immune gene panel (399 genes) relevant to phenotyping human immune cells | BD Rhapsody™ Human Immune Response Panel | |
| Targeted mouse immune gene panel (397 genes) relevant to phenotyping mouse immune cells | BD Rhapsody™ Mouse Immune Response Panel | |
| Targeted human T cell gene panel (259 genes) relevant to T cell biology | BD Rhapsody™ Human T-Cell Expression Panel | |
| Whole Transcriptome Analysis (WTA) enables identification of the most differentially expressed genes in your samples. The WTA data can be used for cell type identification and to construct a targeted panel tailored for your samples of interest | BD Rhapsody™ WTA Reagent Kit 4 Pack | |
| Cytokine Analysis | Cytometric bead array to measure human cytokine(s) in serum, plasma and cell culture supernatant samples | BD® CBA Human Inflammatory Cytokine Kit BD® CBA Human Th1/Th2 Cytokine Kit BD® CBA Human Th1/Th2 Cytokine Kit II BD® CBA Human Th1/Th2/Th17 Cytokine Kit |
| Vaccine Research Biomarkers Therapeutics |
Detection of T and B cell clonotypes in samples of interest | Validated V(D)J CDR3 protocol that works with BD Rhapsody™ Targeted Panels, Sample Multiplexing Kit, and BD® AbSeq Antibodies |
*Please contact your sales representative to request a quote.
| Research Area | Research Application | Recommended Research Panel | |||
|---|---|---|---|---|---|
| Viral Immune Response | Assess the expression of multiple T cell inhibitory receptors (PD-1, TIM-3, LAG-3, CTLA-4, BTLA, TIGIT) on naïve and different memory T cell subsets |
T Cell Exhaustion Panel | |||
| Marker | Dye | Clone | Cat. No | ||
| CD3 | PerCP-Cy5.5 | UCHT1 | 560835 | ||
| CD4 | APC-R700 | RPA-T4 | 564975 | ||
| CD8 | APC-H7 | SK1 | 560179 | ||
| CD45RA | BV650 | HI100 | 563963 | ||
| CD197 (CCR7) | FITC | 150503 | 561271 | ||
| CD95 | BV480 | DX2 | 746675 | ||
| TIGIT | BV421 | 741182 | 747844 | ||
| CD152 (CTLA-4) | PE | BNI3 | 555853 | ||
| CD223 (LAG-3) | Alexa Fluor® 647 | T47-530 | 565716 | ||
| CD272 (BTLA) | BV605 | J168-540 | 743986 | ||
| CD279 (PD-1) | PE-Cy7 | EH12.1 | 561272 | ||
| CD366 (TIM-3) | BV786 | 7D3 | 742857 | ||
| Viral Immune Response | Identification of T helper cell (Th) subsets (Th1, Th2, Th17, Th22), follicular T helper cell (Tfh) subsets, regulatory T cell (Treg) subsets, and follicular regulatory T cell (Tfr) subsets |
T Cell Subset Panel | |||
| Marker | Dye | Clone | Cat. No | ||
| Live/Dead | 7-AAD | N/A | 559925 | ||
| CD3 | Alexa Fluor® 700 | UCHT1 | 557943 | ||
| CD4 | APC-H7 | SK3 | 641398 | ||
| CD45RA | BV605 | HI100 | 562886 | ||
| CD127 | BV711 | HIL-7R-M21 | 563165 | ||
| CD25 | BB515 | 2A3 | 564467 | ||
| CD183 (CXCR3) | PE-Cy7 | 1C6/CXCR3 | 560831 | ||
| CD185 (CXCR5) | BV480 | RF8B2 | 566142 | ||
| CD194 (CCR4) | BV421 | 1G1 | 562579 | ||
| CD196 (CCR6) | BV786 | 11A9 | 563704 | ||
| CD294 (CRTH2) | PE | BM16 | 563665 | ||
| CCR10 | APC | 1B5 | 564771 | ||
BD Biosciences also offers a large and diverse portfolio of high-quality reagents to meet your specific experimental needs and enables the optimization and design of your own assay. Explore the availability of additional reagents.
The immune response to a virus such as SARS-CoV-2 can be tracked in the blood. Multicolor flow cytometry is one of the most powerful tools with which to identify, for example, alterations in the immune cell landscape in response to viral infection. BD Biosciences has a broad catalog of flow cytometry reagents to aid in the analysis and isolation of cells of the innate and adaptive immune system.
For example, T cells are a key component of viral immunity, not only indirectly fighting viral infections, but also in helping to mount a successful antibody response to provide lasting immunity. The table below shows a representative list of high-quality, flow cytometry–tested antibodies available in a broad range of colors that enable a comprehensive study of murine and human T cell biology.
| Type of Cell | CD8+ Cytotoxic T Lymphocytes (CTLs) | CD8+ Exhausted CTLs | CD4+ Th1 | CD4+ Th17 | CD4+ Tfh | CD4+ Tregs | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Main Function | Kill virus-infected cells | Activated but have lost cytotoxic activity | Promote cell-mediated response | Enhance neutrophil and macrophage recruitment | Regulate development of antigen specific B cell development and antibody production |
Immune regulation | |||||
| Pathogens Targeted | Viruses and some intracellular pathogens | Intracellular pathogens | Extracellular pathogens | ||||||||
| Extracellular Markers | CD8 | CD279 (PD-1) CD152 (CTLA-4) CD223 (LAG-3) CD366 (TIM-3) TIGIT CD159a (NKG2A) |
CD4 CD183 (CXCR3) |
CD4 CD196 (CCR6) |
CD4 CD185 (CXCR5) |
CD4 CD25 |
|||||
| Differentiation Cytokines | IFN-γ IL-2 IL-12 |
TGF-β IL-6 IL-21 |
IL-12 IL-6 |
TGF-β IL-12 |
|||||||
| Hallmark Cytokines | IFN-γ TNF IL-2 |
IFN-γ TNF IL-2 |
IL-17A IL-17F IL-21 TNF |
IL-21 | TGF-β IL-10 |
||||||
| Transcription Factors | Eomes | IRF4 | T-bet Stat1 Stat6 |
RORγt | Bcl-6 MAF |
FoxP3 Smad3 Stat5 |
|||||
BD offers contract manufacturing of pre-aliquoted, performance-optimized multicolor panels for flow cytometry in a dried down, ready to use format. The dried multicolor panels reduce inter-experiment variability and come with long shelf lives making them ideal choices for multisite and longitudinal studies.
Proper cytokine response is important for the clearance of any virus. In the case of COVID-19, early research suggests that overactive responses leading to cytokine release syndrome may contribute to more severe presentation of the disease1, 2. Some cytokines that have been identified as abnormally high in COVID-19 samples include:
BD Biosciences offers different solutions for comprehensive measurement of cytokine production, either at the single-cell (intracellular flow cytometry, BD FastImmune™ Cytokine Detection System) or bulk level (BD® Cytometric Bead Array, ELISA) for COVID-19 research.
With streamlined and highly reproducible intracellular cytokine staining, the BD FastImmune System is designed to meet the needs of applied research on human samples. As a complete and optimized system, it is particularly well suited for research studies assessing immune responses to virus or vaccine candidates.
BD Biosciences provides a range of BD FastImmune Multicolor or Single-Color Cytokine Reagents, produced under RUO (GMP) conditions, for antibody staining, including selected sample-activation and sample-processing reagents.
Available Cocktails:
Selected list of relevant single-color BD FastImmune Reagents for analysis of cytokine and degranulation marker expression.
| Target | APC | FITC | PE | Activating Reagents |
|---|---|---|---|---|
| CD107a | ||||
| CD2/CD2R | ||||
| CD28/CD49d Costimulatory Reagent | ||||
| IFN-γ | ||||
| IL-13 | ||||
| IL-1ra | ||||
| IL-1α | ||||
| IL-1β | ||||
| IL-2 | ||||
| IL-4 | ||||
| IL-6 | ||||
| IL-8 | ||||
| TNF |
BD® CBA solutions are available in preconfigured kits or in an open, configurable format for unique needs.
BD CBA Flex Sets provide an open and configurable method of detection so that researchers can build their own multiplexes for protein quantitation as low as 10 pg/mL.
BD CBA Enhanced Sensitivity Flex Sets are capable of detecting cytokine concentrations as low as 0.274 pg/mL.
BD CBA Kits are preconfigured for achieving consistent results for routine panels.
Selected list of relevant BD CBA Flex Sets:
BD Biosciences offers three convenient ELISA reagent formats for quantitation of cytokines and other soluble proteins.
Individual reagents are comprised of unlabeled capture antibodies, biotinylated detection antibodies and protein standards offering a wide range of specificities and assay design flexibility. BD OptEIA™ Sets include reagents for five or twenty 96-well plates and pre-coated 96-well plates. All three BD Biosciences sandwich ELISA formats provide fast, easy quantitation of soluble analytes and total response analysis.
Selected list of relevant BD OptEIA™ ELISA Sets:
Utilize the cutting-edge antibody-oligo technology in the form of BD AbSeq Antibodies to probe up to 100 different cell surface proteins at a single-cell level, while simultaneously performing single-cell RNA analyses. Multiomic research using BD AbSeq Antibodies enables deeper characterization of your immune populations of interest and the potential discovery of novel cell immune signatures.
Flow cytometry has been a common approach to analyze cells and sort them to near-purity for decades, and more recently, the analysis of small entities such as virus and exosomes have become more mainstream. BD Biosciences portfolio of cell analyzers offers the solutions necessary for your COVID-19 related research experiments.
The BD FACSCelesta Flow Cytometer is designed to make high-performance, multicolor flow cytometry accessible to individual labs analyzing up to 14 parameters. Drive your fundamental research in viral immune response forward without waiting for the core lab.
The BD FACSLyric Flow Cytometer is an IVD instrument and can be used in research as well. Upgradeable from 4 to 12 colors, the BD FACSLyric Flow Cytometer offers high resolution and simplified standardization across instruments and labs, enabling collaboration and accelerating translational research. These make the BD FACSLyric Flow Cytometer a powerful tool for COVID-19 research. For more information on the BD FACSLyric Flow Cytometer contact your local representative.
Offering customized solutions for high-parameter analysis, the BD FACSymphony Cell Analyzers can scale up to meet your multicolor needs. When your SARS-CoV-2 research relies on either broad or deep high-parameter phenotypic characterization of specific subpopulations of immune cells, rely on the BD FACSymphony Analyzer.
BD has led the way for 40 years in cell sorting. BD sorters combined with custom biosafety cabinets with integrated aerosol management systems from The Baker Company have been verified to provide product and personnel protection according to several bioprotection standards. In addition, the BD FACSAria™ product family and BD FACSymphony™ S6 Containment Systems have been verified using the recommended Cyclex-d/Dragon Green microsphere assay1. Information about a new SARS-CoV-2 sorting protocol is available at the ISAC Biosafety website.
A truly easy-to-use cell sorter for your own lab, the BD FACSMelody makes the complex world of flow cytometry and sorting available to more researchers. It combines proven BD technology with new automation and simplified software to deliver high-performance results in less time. The BD FACSMelody Cell Sorter provides an easy solution for purification of immune cells of interest for downstream functional or multiomic assays for research use.
The BD FACSAria Fusion Cell Sorter delivers exceptional multicolor performance and ease-of-use, combined with best-in-class biosafety expertise for an advanced cell sorter and biosafety solution. Purification of antigen-specific T and B cells for downstream functional assays is a major application in vaccine research, and the BD FACSAria Fusion Cell Sorter is built to deliver on this front.
Building on the BD FACSAria Fusion biosafety solution, the BD FACSymphony S6 Cell Sorter adds high-parameter analysis to isolate populations based on more than 20 parameters and 6-way sorting capabilities to isolate more populations from one precious sample. Transfer panels from the BD FACSymphony A5 Cell Analyzer to isolate ultraspecific immune cell subpopulations with complex phenotypes in order to research antigen–specific cell subsets.
Perform multiomic analyses by probing protein and RNA information of immune cells simultaneously. Utilize BD Rhapsody’s multiomic data to discover novel immune subsets and study in depth the molecular drivers of immune cell activation and exhaustion in response to viral infection. You can also perform T and B cell receptor repertoire analysis that could potentially enable identification and tracking of vaccine-specific clonotypes expanded upon vaccination or discovery of novel immune cell types responding to infection.
This additional instrument-related information may be helpful to you or your lab during this time. Please see the Support tab for contact information for any additional questions.
BD Biosciences offers powerful informatics tools to complement your flow cytometry and multiomic analysis. These workflows are used by scientists in the lab to enable data insights in infectious disease and vaccine research. Supporting research is our top priority. In response to the increased need to work remotely and to limit time spent in laboratories during this pandemic, we are temporarily offering our users special remote access to FlowJo™ Software to ensure your important research analysis can continue.
FlowJo™ Software is the leading platform for single-cell flow cytometry analysis that helps your research stand out with accessible features for immunophenotyping, cell cycle, proliferation, kinetics studies, quantitative population comparison, plate screening assays and more.
SeqGeq™ Software v1.6 analyzes data from RNA-Seq and single-cell RNA-Seq experiments, providing tools to extract genes and cells of interest and putting transcriptome analyses back in the hands of bench scientists. Explore, visualize and shape your next-gen sequencing data with interactive graphing tools that are designed to help you focus on the insights that matter most.
We offer a variety of support and training for when you need it most:
For information on BD’s comprehensive COVID-19 response efforts—including product availability, status of BD operations and business continuity planning—visit bd.com/COVID-19
To enable principal investigators in basic and translational research labs to obtain answers to key scientific questions, BD Biosciences has established a multi-disciplinary COVID-19 response team. Comprising of BD application specialists in flow cytometry and Multi-Omics, this team will provide researchers with technical support and knowhow to gain insights into important scientific aspects of COVID-19 virology.
In times of limited onsite interactions due to COVID-19 restrictions, BD has reinforced its remote support capabilities. BD Assurity Linc™ Remote Services, now powered by BD’s RSS technology, provides remote access into BD systems, allowing BD Service and Support teams to monitor your instruments and address technical issues remotely in a timely manner.
Enjoy the benefits of reduced service visits, faster issue resolution and high-level security.
If you are interested in installing this software or learning more, please contact techsupport@bd.com.
Class 1 Laser Product
BD FACSLyric™ is CE marked in compliance with the European In Vitro Diagnostic Medical Device Directive 98/79/EC.
All other products are for Research use only. Not for use in diagnostic or therapeutic procedures.
This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.
This site uses cookies to better deliver content. If you do not wish to enable cookies please configure this here. For more detailed information on specific cookies written for each of the categories below and their purpose please refer to our cookie policy.
Essential and Functional cookies
These cookies collect information on how a website is used, they do not store personal information.
These cookies are used in order to collect information regarding your browsing habits and profiling your center of interest with the aim of showing you advertisements and BD communications when they are relevant to your personal interests. Please consult our cookie policy for more information.
